Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates to terminology during the transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T02:07:12.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T01:55:22.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T02:32:13.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error, indicating the content is not accessible. This change blocks access to the NCT03525678 study details on ClinicalTrials.gov and updates the page header to reflect the error.
    Difference
    22%
    Check dated 2026-09-20T01:14:13.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.6, a 2017 NIH funding note was added, and a new bibliographic citation (Tacchetti et al., Expert Rev Anticancer Ther, 2024) was included to reference recent literature related to antibody-drug conjugates in multiple myeloma.
    Difference
    0.1%
    Check dated 2026-08-29T20:56:20.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page gains new contextual references to the disease (Multiple myeloma) and related topics, including a MedlinePlus Genetics link, expanding readers' access to related information.
    Difference
    0.1%
    Check dated 2026-08-22T21:43:43.000Z thumbnail image

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.